A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1998

Conditions
HIV InfectionsPregnancy
Interventions
DRUG

Nevirapine

Trial Locations (16)

10029

Mount Sinai Med Ctr / Pediatrics, New York

90033

Los Angeles County - USC Med Ctr, Los Angeles

94110

San Francisco Gen Hosp, San Francisco

606143394

Chicago Children's Memorial Hosp, Chicago

606371470

Univ of Chicago Children's Hosp, Chicago

900951752

UCLA Med Ctr / Pediatric, Los Angeles

905022004

Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles

920930672

UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla

941430105

UCSF / Moffitt Hosp - Pediatric, San Francisco

06032

Univ of Connecticut / Farmington, Farmington

06106

Connecticut Children's Med Ctr - Pediatric, Hartford

021155724

Children's Hosp of Boston, Boston

02118

Boston City Hosp / Pediatrics, Boston

016550001

Univ of Massachusetts Med School, Worcester

071032714

Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark

009367344

San Juan City Hosp, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH